NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
FLINDR THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FLINDR THERAPEUTICS
ST13
US500000098451969Class
1, 5, 42
Filing
98451969
Registration
7798473
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/20/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/15/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Amsterdam, NL
Examiner
AIKENS, RONALD E
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Immagene B.V.
Representatives
Erica R. Halstead Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparationsbiologically compatible chemical substances for scientificlaboratoryclinical and medical research; biological tissuemammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientificlaboratoryclinical and medical research; therapeutic tissuetherapeutic tissue comprising or derived from stem cells or progenitor cellscompositions comprising or derived from the therapeutic tissues for scientificlaboratoryclinical and medical research
Class 5
Pharmaceuticalsmedical and veterinary preparations for use in oncology; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology
Class 42
Pharmaceutical drug discovery and development services; scientific services and researchdevelopment and design relating thereto in the field of oncology; medical research; technological servicesresearch and design relating thereto in the fields of small molecule therapeutics; design and development of medical technology; design and development of medical diagnostic apparatus; consultancy services in the field of technological development of small molecule therapeutics; industrial analysis and industrial research services in the fields of small molecule therapeutics; design and development of computer hardware and software; design and development of small molecule therapeutics hardware; design and development of computer software for use with small molecule therapeutics hardware; clinical research in the fields of small molecule therapeutics; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodiesimmuno-oncologyinflammationhematology and infectious disease; Medical and scientific researchconducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying of therapeutics for medical purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology; consultancy services relating to research and development in the field of therapeutics
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/10/2025
ALIE
ASSIGNED TO LIE
03/10/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/07/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/10/2025
GNSL
LETTER OF SUSPENSION E-MAILED
02/10/2025
CNSL
SUSPENSION LETTER WRITTEN
02/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2024
GNRT
NON-FINAL ACTION E-MAILED
10/07/2024
CNRT
NON-FINAL ACTION WRITTEN
10/07/2024
DOCK
ASSIGNED TO EXAMINER
09/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/17/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/17/2024
NWAP
NEW APPLICATION ENTERED
03/17/2024
Continuous trademark protection
Get notified about every new filing that threatens FLINDR THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.